- Home
- » Tags
- » Astellas Pharma
Top View
- Annual Report 2004 Annual Report 2004 Annual Report 2004
- The Position Limits on Securities Options (Applied from May 12, 2017) Code Underlying Security New Old
- Press Release
- Ranking of Stocks by Market Capitalization(As of End of May 2013) 1St Section
- Joint Storage and Transportation of Pharmaceuticals in Hokkaido by Astellas, Takeda, Teva Takeda Pharma and Teva
- Press Release
- Ranking of Stocks by Market Capitalization(As of End of Jan.2021) 1St Section
- List of Employers of Graduates
- Annual Report 2020
- Partnering Data As of November 2018
- Forum for Innovative Regenerative Medicine Members As of July 1, 2021
- 2018 Annual Meeting Program (Japan Affiliate) Venue: Tower Hall Funabori 〒134-0091 4-1-1 Funabori Edogaw-Ku Tokyo
- Astellas Pharma US, Inc Ate of Tokyo-Based Astellas Pharma Inc., a Top 1 Astellas Way 20 Global Pharmaceutical Research Company
- Participant List
- Stoxx® Asia/Pacific 50 Index
- ANNUAL REPORT 2018 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan
- See Our International Companies
- For the Year Ended March 31, 2011
- Directors, Corporate Auditors and Corporate Officers
- Active Investor Social Update First Quarter, 2016
- Forum for Innovative Regenerative Medicine Members
- Citi Pure Estimates Momentum Japan Long-Short Net TR Index (CIISEMJT)
- Monthly Trading Value of Most Active Stocks (Aug.2014) 1St Section
- Forum for Innovative Regenerative Medicine Members
- CSR Report 2007 Astellas
- Dividend Forecasting
- Notice of Convocation of the 12Th Term Annual Shareholders Meeting
- The Largest Pharmaceutical Companies Worldwide Analysis of Key Financial Indicators for Fiscal Years 2017, 2018 and 2019 About the Study
- Pharma Intelligence Scrip Asia 100
- Astellas Concludes Agreement with Microbiopharm Japan on Transfer of Kiyosu Plant Business
- Disclosure Summary
- Dec. 20, 2019 Notification with New Appointment of the Executive Officers
- CORPORATE GOVERNANCE REPORT Astellas Pharma, Inc
- BIO Digital Sample Attendee List As of June 5, 2020
- Switzerland Newsletter Switzerland Newsletter
- Lymphoma: a Single-Arm, Open-Label, Phase 2 Study
- June 30, 2021 Holdings (PDF)
- Notice of Convocation of the 15Th Term Annual Shareholders Meeting
- ICMJE Form for Disclosure of Potential Conflicts of Interest
- 1 the Notice of Convocation (Securities Code 4503) May 27, 2019 To: Shareholders Notice of Convocation of the 14Th Term Annual S
- CORPORATE GOVERNANCE REPORT Astellas Pharma Inc
- Ranking of Stocks by Market Capitalization(As of End of May 2021) 1St Section
- FOR IMMEDIATE RELEASE December 18, 2007 Announcement of the Launch of the Pulmonary Arterial Hypertension Agent Careload LA
- CFD Type IB Symbol Product Description Symbol Currency Share
- Astellas Transfers Its Global Dermatology Business to LEO Pharma
- I N T E L L E C T U a L P R O P E R T Y R E P O
- Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults
- Editorial Policy
- Astellas Donates 6 Wheelchair Vans Through the Flying Star Fund, an Employee-Led Social Contribution Fund
- Astellas Donates 6 Wheelchair Vans Through the Flying Star Fund, an Employee-Led Social Contribution Fund
- Ranking of Stocks by Market Capitalization(As of End of Feb.2013)
- Aeon Company, Ltd...Daifuku Co
- Astellas Pharma US, Inc. Company Facts
- Australian Capital Territory Listed Company Shareholdings As at 30 June 2020
- Volunteer Disclosure Report
- Japan 500 2012 A-Z
- MSCI Japan ESG Rating Select 50 Index (JPY) (GROSS)
- Annual Report 2006
- Policy and Medicine Applicable